New hope for AML patients: drug combo trial seeks better control
Disease control
Completed
This study tested if adding a new oral drug called quizartinib to standard chemotherapy works better and is safe for adults newly diagnosed with a specific type of acute myeloid leukemia (AML). Researchers compared the quizartinib combination against standard chemotherapy plus a …
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC